Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
4DMedical Ltd ( (AU:4DX) ) has shared an announcement.
4DMedical Limited has applied to the ASX for quotation of new fully paid ordinary shares issued following the exercise or conversion of existing options or other convertible securities. The securities, which were issued on 2 January 2026, represent an administrative step to have these newly created shares admitted to trading, modestly increasing the company’s quoted capital base and enabling holders of the converted instruments to participate as ordinary shareholders in the market.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$3.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited (ASX:4DX) is an Australian-listed medical technology company focused on advanced respiratory imaging and analysis. It develops and commercialises software and imaging solutions designed to improve the diagnosis and management of lung and respiratory diseases, targeting hospitals, clinicians and healthcare systems seeking more precise, non-invasive pulmonary diagnostics.
Average Trading Volume: 4,698,325
Technical Sentiment Signal: Buy
Current Market Cap: A$2.06B
For a thorough assessment of 4DX stock, go to TipRanks’ Stock Analysis page.